Table: begin end state 1 50 cytoplasmic 51 69 transmembrane 70 74 non-cytoplasmic 75 96 transmembrane 97 107 cytoplasmic 108 132 transmembrane 133 133 non-cytoplasmic 134 158 transmembrane 159 172 cytoplasmic 173 196 transmembrane 197 207 non-cytoplasmic 208 227 transmembrane 228 255 cytoplasmic 256 275 transmembrane 276 293 non-cytoplasmic 294 312 transmembrane 313 323 cytoplasmic 324 343 transmembrane 344 348 non-cytoplasmic 349 372 transmembrane 373 383 cytoplasmic 384 405 transmembrane 406 416 non-cytoplasmic 417 435 transmembrane 436 445 cytoplasmic
Input: >Ga0059261_3322 Ga0059261_3322 Arabinose efflux permease MARIPGMIGVPADGDAPLDTRPAHAVPLDRRTRARAAVAGSVGNLIEWYDFYAYAYTALY FASAFFPAGDRTAQLLNVAAIYAAGFLIRPLGGWFFGRYADRHGRRAAMIASVVLMGAGS LLVGVLPTYATIGAAAPALLLVARLMQGFSTGGQYGAAATYLSEIAEPGKRGFYASFQFV TLIGGQLFALLVVFALQSTMSETAIREWGWRLPFLLGAVLAGVFILFRDVMHETAEPASK GEDAGSLKALFQHPRAMFVVMALSAAGAVTLYTFTTYMQKYLVNTAGMDVASASRTMLIV TFAFLLLQPVLGTLSDRIGRRTNLLIFSGGMTLFAVPLLGAIGQAQTMWSAGLLVFAALA IMSFYTSVSGLFKAELFPARVRALGVGLGHAIASAIFGGTAEWAALMLKQMGHEGLFAWY VSAVCAVAFVVAWQMREPRAHGHLR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server